Developmental signaling pathways in brain tumor-derived stem-like cells
- PMID: 18000980
- DOI: 10.1002/dvdy.21381
Developmental signaling pathways in brain tumor-derived stem-like cells
Abstract
Recently, a subpopulation of cells highly efficient in tumor initiation and growth has been isolated from brain tumors. Of interest, these brain tumor initiating cells exhibit many stem-like properties, including self-renewal, extended proliferation, and multipotency, and are both phenotypically and genetically similar to normal neural stem cells (NSCs). Aberrant expression of developmental pathways, such as WNT, Hedgehog, Notch, and transforming growth factor-beta/bone morphogenetic protein, have been demonstrated in brain tumors, and extrinsic regulation of these pathways may be used to target brain tumor stem-like cells (BTSCs) and form the basis of novel biological therapies. Because of regulatory redundancy during normal development, future therapeutic strategies to inhibit BTSC-mediated tumor growth and minimize NSC-related deleterious effects may require detailed understanding and regulation of multiple cellular mechanisms. This review analyzes the role developmental pathways play in brain tumors, focusing on the potential effects of pathway regulation on BTSC-driven tumorigenesis.
2007 Wiley-Liss, Inc
Similar articles
-
Morphing into cancer: the role of developmental signaling pathways in brain tumor formation.J Neurobiol. 2005 Sep 15;64(4):458-75. doi: 10.1002/neu.20166. J Neurobiol. 2005. PMID: 16041741 Review.
-
Cancer stem cells in nervous system tumors.Oncogene. 2004 Sep 20;23(43):7267-73. doi: 10.1038/sj.onc.1207946. Oncogene. 2004. PMID: 15378086 Review.
-
Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors.Cancer Res. 2006 Aug 1;66(15):7445-52. doi: 10.1158/0008-5472.CAN-06-0858. Cancer Res. 2006. PMID: 16885340
-
New hope for cancer treatment: exploring the distinction between normal adult stem cells and cancer stem cells.Pharmacol Ther. 2008 Jul;119(1):74-82. doi: 10.1016/j.pharmthera.2008.04.008. Epub 2008 May 20. Pharmacol Ther. 2008. PMID: 18562010 Review.
-
[Research progress of neural stem cells signal transduction pathway].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2008 Apr;22(4):492-5. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2008. PMID: 18575456 Review. Chinese.
Cited by
-
Mitogen activated protein kinase signaling pathways participate in the active principle region of Buyang Huanwu decoction-induced differentiation of bone marrow mesenchymal stem cells.Neural Regen Res. 2012 Jun 25;7(18):1370-7. Neural Regen Res. 2012. PMID: 25657669 Free PMC article.
-
LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem-like cells.Brain Pathol. 2013 Jan;23(1):60-72. doi: 10.1111/j.1750-3639.2012.00618.x. Epub 2012 Aug 30. Brain Pathol. 2013. PMID: 22805276 Free PMC article.
-
Progress on potential strategies to target brain tumor stem cells.Cell Mol Neurobiol. 2009 Mar;29(2):141-55. doi: 10.1007/s10571-008-9310-1. Epub 2008 Sep 10. Cell Mol Neurobiol. 2009. PMID: 18781384 Free PMC article. Review.
-
The cancer stem cell paradigm: a new understanding of tumor development and treatment.Expert Opin Ther Targets. 2010 Jun;14(6):621-32. doi: 10.1517/14712598.2010.485186. Expert Opin Ther Targets. 2010. PMID: 20426697 Free PMC article. Review.
-
PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells.Mol Cell Biochem. 2011 Mar;349(1-2):149-57. doi: 10.1007/s11010-010-0669-1. Epub 2010 Nov 26. Mol Cell Biochem. 2011. PMID: 21110069
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical